Literature DB >> 1923804

A DNA binding domain is contained in the C-terminus of wild type p53 protein.

O S Foord1, P Bhattacharya, Z Reich, V Rotter.   

Abstract

In the present study we evaluated the DNA binding activity of wild type and mutant p53 proteins that were isolated from bacterial expression vectors. A comparison of the binding activities of the various purified p53 proteins, assessed by their ability to bind DNA cellulose columns, indicated that wild type p53 has a higher affinity to DNA than have mutant p53 forms. Furthermore, only wild type p53 was able to bind genomic DNA upon electrophoretic protein blotting. As specific deletion of the C-terminal region of wild type p53 totally abolished binding to genomic DNA, it was concluded that the 47 C-terminal amino acids contain the DNA binding region. The fact that the N-terminus contains a transcription activation region whereas the C-terminus contains a DNA binding domain places p53 in the family of typical transcription factors. Our experiments show that the topographical positioning of these domains plays an important role in the activity of wild type p53.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923804      PMCID: PMC328875          DOI: 10.1093/nar/19.19.5191

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  58 in total

1.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

2.  Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

Authors:  J Martinez; I Georgoff; J Martinez; A J Levine
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

Review 3.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

4.  Meth A fibrosarcoma cells express two transforming mutant p53 species.

Authors:  D Eliyahu; N Goldfinger; O Pinhasi-Kimhi; G Shaulsky; Y Skurnik; N Arai; V Rotter; M Oren
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Prediction of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

7.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

8.  p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells.

Authors:  W G Dippold; G Jay; A B DeLeo; G Khoury; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.

Authors:  V Rotter; O N Witte; R Coffman; D Baltimore
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

10.  The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation.

Authors:  M Schuermann; M Neuberg; J B Hunter; T Jenuwein; R P Ryseck; R Bravo; R Müller
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

View more
  30 in total

1.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  A transcriptionally active DNA-binding site for human p53 protein complexes.

Authors:  W D Funk; D T Pak; R H Karas; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 3.  Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins.

Authors:  E C LaCasse; Y A Lefebvre
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

4.  The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.

Authors:  G Selivanova; V Iotsova; E Kiseleva; M Ström; G Bakalkin; R C Grafström; K G Wiman
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

5.  The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.

Authors:  N Almog; R Li; A Peled; D Schwartz; R Wolkowicz; N Goldfinger; H Pei; V Rotter
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 6.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

7.  Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.

Authors:  K Will; G Warnecke; S Bergmann; W Deppert
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

8.  Direct binding of DNA by tumor suppressor menin.

Authors:  Ping La; Albert C Silva; Zhaoyuan Hou; Haoren Wang; Robert W Schnepp; Nieng Yan; Yigong Shi; Xianxin Hua
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

9.  Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53.

Authors:  S J Ullrich; K Sakaguchi; S P Lees-Miller; M Fiscella; W E Mercer; C W Anderson; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.

Authors:  G Sauter; G Deng; H Moch; R Kerschmann; K Matsumura; S De Vries; T George; J Fuentes; P Carroll; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.